Patents by Inventor Andrea Rosario BECCARI

Andrea Rosario BECCARI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240342150
    Abstract: The present invention relates to Raloxifene or a pharmaceutically acceptable salt thereof for use in the treatment of an infection caused by one or more variants of SARS-CoV-2 in a subject.
    Type: Application
    Filed: August 3, 2022
    Publication date: October 17, 2024
    Inventors: Andrea Rosario BECCARI, Daniela IACONIS, Carmine TALARICO, Candida MANELFI, Laura SCORZOLINI, Licia BORDI, Giulia MATUSALI, Emanuele NICASTRI
  • Publication number: 20240180889
    Abstract: The present invention relates to the combination of a Selective Estrogen Receptor Modulator (SERM) and a COVID-19 vaccine.
    Type: Application
    Filed: March 31, 2022
    Publication date: June 6, 2024
    Inventors: Marcello ALLEGRETTI, Andrea Rosario BECCARI, Maria Candida CESTA, Elisabetta Maria Ester MAURI, Carmine TALARICO
  • Publication number: 20230233543
    Abstract: The present invention relates to compounds that are able to inhibt functional proteins of COVID-19 virus, SARS-Cov-2.
    Type: Application
    Filed: May 6, 2021
    Publication date: July 27, 2023
    Inventors: Andrea Rosario BECCARI, Candida MANELFI, Carmine TALARICO, Andrea ZALIANI, Gerd GEISSLINGER, Philip GRIBBON, Pieter LEYSSEN
  • Publication number: 20200022957
    Abstract: A suppressor or inhibitor of expression and/or function of 4 a gene, a kinase or ubiquitin ligase, for use in the treatment of a protein conformational disorder is provided.
    Type: Application
    Filed: December 16, 2016
    Publication date: January 23, 2020
    Inventors: Alberto LUINI, Andrea Rosario BECCARI, Ramanath Narayana HEGDE, Seetaraman PARASHURAMAN
  • Patent number: 9409876
    Abstract: The present invention relates to compounds represented by formula (I) and pharmaceutically acceptable salts thereof that are antagonists of the bradykinin B1 receptor. These compounds are useful for the treatment of disorders associated with the bradykinin B1 pathway, in particular pain-related disorders.
    Type: Grant
    Filed: June 13, 2014
    Date of Patent: August 9, 2016
    Assignee: DOMPE' FARMACEUTICI S.P.A.
    Inventors: Andrea Rosario Beccari, Gianluca Bianchini, Chiara Liberati, Michela Fani', Mara Zippoli
  • Publication number: 20140371274
    Abstract: The present invention relates to novel compounds, their use in the prevention or treatment of symptoms and disorders associated with the bradykinin B1 pathway and pharmaceutical compositions containing them.
    Type: Application
    Filed: June 13, 2014
    Publication date: December 18, 2014
    Inventors: Andrea Rosario BECCARI, Gianluca BIANCHINI, Chiara LIBERATI, Michela FANI', Mara ZIPPOLI